Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

Core Insights - Avenue Therapeutics, Inc. is a specialty pharmaceutical company focused on developing and commercializing therapies for neurologic diseases [2] - The company is developing three key assets: AJ201 for spinal and bulbar muscular atrophy, BAER-101 for CNS diseases, and IV tramadol for acute post-operative pain management [2] - CEO Alexandra MacLean will present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on June 27, 2024 [1] Company Overview - Avenue Therapeutics is headquartered in Miami, FL and was founded by Fortress Biotech, Inc. [2] - The company is publicly traded on Nasdaq under the ticker ATXI [2] - The focus on neurologic diseases positions Avenue Therapeutics in a specialized segment of the pharmaceutical industry [2]